Literature DB >> 15095204

Persistent diarrhea, arthritis, and other complications of enteric infections: a pilot survey based on California FoodNet surveillance, 1998-1999.

Judy R Rees1, Mary Ann Pannier, Alexander McNees, Sue Shallow, Frederick J Angulo, Duc J Vugia.   

Abstract

Numerous complications of enteric infections have been described, including persistent diarrhea, reactive arthritis, and Guillain-Barre syndrome. We determined the frequency of self-reported complications of enteric infections in a pilot study in the California site of the Foodborne Diseases Active Surveillance Network. From 1 April 1998 through 31 March 1999, active surveillance identified 1454 infections in Alameda and San Francisco counties, of which 52% were Campylobacter infections, 22% were Salmonella infections, 15% were Shigella infections, 6% were Cryptosporidium infections, 2% were Escherichia coli O157:H7 infections, 2% were Yersinia infections, and 1% were Vibrio infections. We mailed surveys to 1331 eligible participants, and 571 (43%) were returned. A new health problem following infection was reported by 153 (27%) of the respondents: 12 (8%) reported new onset of joint pain and 53 (35%) reported new gastrointestinal symptoms, of whom 38 reported persistent diarrhea, including 2 who reported irritable bowel syndrome. Three respondents reported hair loss. The frequency, nature, and etiology of these complications merit further investigation.

Entities:  

Mesh:

Year:  2004        PMID: 15095204     DOI: 10.1086/381601

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  14 in total

Review 1.  Campylobacter reactive arthritis: a systematic review.

Authors:  Janet E Pope; Adriana Krizova; Amit X Garg; Heather Thiessen-Philbrook; Janine M Ouimet
Journal:  Semin Arthritis Rheum       Date:  2007-03-13       Impact factor: 5.532

Review 2.  Prophylaxis for travelers' diarrhea.

Authors:  Emily Singh; David Redfield
Journal:  Curr Gastroenterol Rep       Date:  2009-08

3.  Yersinia enterocolitica biotype 1A: a possible new trigger of reactive arthritis.

Authors:  Riitta Tuompo; Timo Hannu; Elisa Huovinen; Leila Sihvonen; Anja Siitonen; Marjatta Leirisalo-Repo
Journal:  Rheumatol Int       Date:  2017-09-16       Impact factor: 2.631

Review 4.  Recent advances in reactive arthritis.

Authors:  Ines Colmegna; Luis R Espinoza
Journal:  Curr Rheumatol Rep       Date:  2005-06       Impact factor: 4.592

5.  Arthritis risk after acute bacterial gastroenteritis.

Authors:  A X Garg; J E Pope; H Thiessen-Philbrook; W F Clark; J Ouimet
Journal:  Rheumatology (Oxford)       Date:  2008-01-09       Impact factor: 7.580

6.  Pathogen-specific risk of chronic gastrointestinal disorders following bacterial causes of foodborne illness.

Authors:  Chad K Porter; Daniel Choi; Brooks Cash; Mark Pimentel; Joseph Murray; Larissa May; Mark S Riddle
Journal:  BMC Gastroenterol       Date:  2013-03-08       Impact factor: 3.067

7.  Clinical aspects and self-reported symptoms of sequelae of Yersinia enterocolitica infections in a population-based study, Germany 2009-2010.

Authors:  Bettina M Rosner; Dirk Werber; Michael Höhle; Klaus Stark
Journal:  BMC Infect Dis       Date:  2013-05-23       Impact factor: 3.090

Review 8.  Chronic Gastrointestinal and Joint-Related Sequelae Associated with Common Foodborne Illnesses: A Scoping Review.

Authors:  Kristen Pogreba-Brown; Erika Austhof; Alexandra Armstrong; Kenzie Schaefer; Lorenzo Villa Zapata; D Jean McClelland; Michael B Batz; Maria Kuecken; Mark Riddle; Chad K Porter; Michael C Bazaco
Journal:  Foodborne Pathog Dis       Date:  2019-10-07       Impact factor: 3.788

9.  A study of 279 general outbreaks of gastrointestinal infection in the north-East region of England.

Authors:  Grahame M Tebbutt; Deborah Wilson; Ian Holtby
Journal:  Int J Environ Res Public Health       Date:  2009-02-05       Impact factor: 3.390

10.  Short- and long-term effects of bacterial gastrointestinal infections.

Authors:  Anders Ternhag; Anna Törner; Ake Svensson; Karl Ekdahl; Johan Giesecke
Journal:  Emerg Infect Dis       Date:  2008-01       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.